Wednesday, November 25, 2009

Incontinence Home>
News>
FDA approves gel for overactive bladder

Font size
- A
- A
- A
Email This

Bookmark

Save

FDA approves gel for overactive bladder

(MedPage Today) UPDATED 2009-02-12

The U.S. Food and Drug Administration has approved a new topical gel to help treat symptoms of overactive bladder. Gelnique is a once-daily topical dose of oxybutynin chloride gel that is applied to the thigh, abdomen, upper arm, or shoulder. Researchers say that because the gel is delivered through the skin it is not metabolized in the liver, which means patients may see fewer side effects such as dry mouth and constipation. The drug’s maker says the gel will be available in spring 2009.
Read full story >

See all Incontinence News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on IncontinenceNetwork.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.